Engineered T Cells Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0063087
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.17
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.17 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
The global Engineered T Cells market is valued at million US$ in 2019 and will reach million US$ by the end of 2026, growing at a CAGR of during 2019-2026. The objectives of this study are to define, segment, and project the size of the Engineered T Cells market based on company, product type, end user and key regions.This report studies the global market size of Engineered T Cells in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Engineered T Cells in these regions.
This research report categorizes the global Engineered T Cells market by top players/brands, region, type and end user. This report also studies the global Engineered T Cells market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Market size by Product
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
Market size by End User
Hospitals
Cancer Research Centers
Clinics
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Engineered T Cells market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2019, and forecast to 2026.
To understand the structure of Engineered T Cells market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Engineered T Cells companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Engineered T Cells submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Engineered T Cells are as follows:
History Year: 2014-2019
Base Year: 2019
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Engineered T Cells market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Engineered T Cells Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Engineered T Cells Market Size Growth Rate by Product
1.4.2 Tumor Infiltrating Lymphocytes
1.4.3 T Cell Receptor {TCR}
1.4.4 Chimeric Antigen Receptor (CAR)
1.5 Market by End User
1.5.1 Global Engineered T Cells Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Engineered T Cells Market Size
2.1.1 Global Engineered T Cells Revenue 2014-2025
2.1.2 Global Engineered T Cells Sales 2014-2025
2.2 Engineered T Cells Growth Rate by Regions
2.2.1 Global Engineered T Cells Sales by Regions
2.2.2 Global Engineered T Cells Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Engineered T Cells Sales by Manufacturers
3.1.1 Engineered T Cells Sales by Manufacturers
3.1.2 Engineered T Cells Sales Market Share by Manufacturers
3.1.3 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
3.2 Engineered T Cells Revenue by Manufacturers
3.2.1 Engineered T Cells Revenue by Manufacturers (2014-2019)
3.2.2 Engineered T Cells Revenue Share by Manufacturers (2014-2019)
3.3 Engineered T Cells Price by Manufacturers
3.4 Engineered T Cells Manufacturing Base Distribution, Product Types
3.4.1 Engineered T Cells Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Engineered T Cells Product Type
3.4.3 Date of International Manufacturers Enter into Engineered T Cells Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Engineered T Cells Sales by Product
4.2 Global Engineered T Cells Revenue by Product
4.3 Engineered T Cells Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Engineered T Cells Breakdown Data by End User
6 North America
6.1 North America Engineered T Cells by Countries
6.1.1 North America Engineered T Cells Sales by Countries
6.1.2 North America Engineered T Cells Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Engineered T Cells by Product
6.3 North America Engineered T Cells by End User
7 Europe
7.1 Europe Engineered T Cells by Countries
7.1.1 Europe Engineered T Cells Sales by Countries
7.1.2 Europe Engineered T Cells Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Engineered T Cells by Product
7.3 Europe Engineered T Cells by End User
8 Asia Pacific
8.1 Asia Pacific Engineered T Cells by Countries
8.1.1 Asia Pacific Engineered T Cells Sales by Countries
8.1.2 Asia Pacific Engineered T Cells Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Engineered T Cells by Product
8.3 Asia Pacific Engineered T Cells by End User
9 Central & South America
9.1 Central & South America Engineered T Cells by Countries
9.1.1 Central & South America Engineered T Cells Sales by Countries
9.1.2 Central & South America Engineered T Cells Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Engineered T Cells by Product
9.3 Central & South America Engineered T Cells by End User
10 Middle East and Africa
10.1 Middle East and Africa Engineered T Cells by Countries
10.1.1 Middle East and Africa Engineered T Cells Sales by Countries
10.1.2 Middle East and Africa Engineered T Cells Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Engineered T Cells by Product
10.3 Middle East and Africa Engineered T Cells by End User
11 Company Profiles
11.1 Autolus Limited
11.1.1 Autolus Limited Company Details
11.1.2 Company Business Overview
11.1.3 Autolus Limited Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Autolus Limited Engineered T Cells Products Offered
11.1.5 Autolus Limited Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bellicum Pharmaceuticals Engineered T Cells Products Offered
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Cells Medica
11.3.1 Cells Medica Company Details
11.3.2 Company Business Overview
11.3.3 Cells Medica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cells Medica Engineered T Cells Products Offered
11.3.5 Cells Medica Recent Development
11.4 Elli Lilly and Company
11.4.1 Elli Lilly and Company Company Details
11.4.2 Company Business Overview
11.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Elli Lilly and Company Engineered T Cells Products Offered
11.4.5 Elli Lilly and Company Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Company Business Overview
11.5.3 Gilead Sciences Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Gilead Sciences Engineered T Cells Products Offered
11.5.5 Gilead Sciences Recent Development
11.6 Juno Therapeutics
11.6.1 Juno Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Juno Therapeutics Engineered T Cells Products Offered
11.6.5 Juno Therapeutics Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Engineered T Cells Products Offered
11.7.5 Novartis Recent Development
11.8 Oxford Biomedica
11.8.1 Oxford Biomedica Company Details
11.8.2 Company Business Overview
11.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Oxford Biomedica Engineered T Cells Products Offered
11.8.5 Oxford Biomedica Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Engineered T Cells Products Offered
11.9.5 Pfizer Recent Development
11.10 Precision Bioscience
11.10.1 Precision Bioscience Company Details
11.10.2 Company Business Overview
11.10.3 Precision Bioscience Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Precision Bioscience Engineered T Cells Products Offered
11.10.5 Precision Bioscience Recent Development
11.11 Redmile Group
11.12 Seeking Alpha
11.13 Unum Therapeutics
12 Future Forecast
12.1 Engineered T Cells Market Forecast by Regions
12.1.1 Global Engineered T Cells Sales Forecast by Regions 2019-2025
12.1.2 Global Engineered T Cells Revenue Forecast by Regions 2019-2025
12.2 Engineered T Cells Market Forecast by Product
12.2.1 Global Engineered T Cells Sales Forecast by Product 2019-2025
12.2.2 Global Engineered T Cells Revenue Forecast by Product 2019-2025
12.3 Engineered T Cells Market Forecast by End User
12.4 North America Engineered T Cells Forecast
12.5 Europe Engineered T Cells Forecast
12.6 Asia Pacific Engineered T Cells Forecast
12.7 Central & South America Engineered T Cells Forecast
12.8 Middle East and Africa Engineered T Cells Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Engineered T Cells Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Engineered T Cells Product Picture
Table Engineered T Cells Market Segments
Table Key Manufacturers Engineered T Cells Covered
Table Global Engineered T Cells Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Engineered T Cells Sales Market Share by Product 2014-2025
Figure Tumor Infiltrating Lymphocytes Product Picture
Table Major Manufacturers of Tumor Infiltrating Lymphocytes
Figure T Cell Receptor {TCR} Product Picture
Table Major Manufacturers of T Cell Receptor {TCR}
Figure Chimeric Antigen Receptor (CAR) Product Picture
Table Major Manufacturers of Chimeric Antigen Receptor (CAR)
Table Global Engineered T Cells Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Cancer Research Centers
Figure Clinics
Figure Engineered T Cells Report Years Considered
Figure Global Engineered T Cells Market Size 2014-2025 (Million US$)
Figure Global Engineered T Cells Sales 2014-2025 (K Units)
Table Global Engineered T Cells Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Engineered T Cells Sales by Regions 2014-2019 (K Units)
Table Global Engineered T Cells Sales Market Share by Regions 2014-2019
Figure Global Engineered T Cells Sales Market Share by Regions 2014-2019
Figure 2018 Global Engineered T Cells Sales Market Share by Regions
Table Global Engineered T Cells Revenue by Regions 2014-2019 (Million US$)
Table Global Engineered T Cells Revenue Market Share by Regions 2014-2019
Figure Global Engineered T Cells Revenue Market Share by Regions 2014-2019
Figure 2018 Global Engineered T Cells Revenue Market Share by Regions
Table Global Engineered T Cells Sales by Manufacturers (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by Manufacturers (2014-2019)
Figure Global Engineered T Cells Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Engineered T Cells Revenue by Manufacturers (2014-2019) (Million USD)
Table Engineered T Cells Revenue Share by Manufacturers (2014-2019)
Figure Engineered T Cells Value Share by Manufacturers in 2018
Table Key Manufacturers Engineered T Cells Price (2014-2019) (USD/Unit)
Table Engineered T Cells Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Engineered T Cells Product Type
Table Date of International Manufacturers Enter into Engineered T Cells Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by Product (2014-2019)
Figure Global Engineered T Cells Sales Market Share by Product (2014-2019)
Figure Global Engineered T Cells Sales Market Share by Product in 2018
Table Global Engineered T Cells Revenue by Product (2014-2019) (Million US$)
Table Global Engineered T Cells Revenue Share by Product (2014-2019)
Figure Global Engineered T Cells Revenue Market Share by Product (2014-2019)
Figure Global Engineered T Cells Revenue Market Share by Product in 2018
Table Engineered T Cells Price by Product 2014-2019 (USD/Unit)
Table Global Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by End User (2014-2019)
Figure Global Sales Engineered T Cells Market Share by End User (2014-2019)
Figure Global Sales Engineered T Cells Market Share by End User in 2018
Figure North America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure North America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table North America Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 North America Engineered T Cells Sales Market Share by Countries
Table North America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table North America Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Engineered T Cells Revenue Market Share by Countries
Figure United States Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure United States Engineered T Cells Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Canada Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table North America Engineered T Cells Sales by Product (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 North America Engineered T Cells Market Share by Product
Table North America Engineered T Cells Sales by End User (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 North America Engineered T Cells Market Share by End User
Figure Europe Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Europe Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Engineered T Cells Sales Market Share by Countries
Table Europe Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Europe Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Engineered T Cells Revenue Market Share by Countries
Figure Germany Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Germany Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure France Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure France Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure UK Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Italy Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Russia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Europe Engineered T Cells Market Share by Product
Table Europe Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Europe Engineered T Cells Market Share by End User
Figure Asia Pacific Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Sales Market Share by Countries
Table Asia Pacific Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Revenue Market Share by Countries
Figure China Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure China Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Japan Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Korea Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure India Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure India Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Australia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Market Share by Product
Table Asia Pacific Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Market Share by End User
Figure Central & South America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Engineered T Cells Sales Market Share by Countries
Table Central & South America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Engineered T Cells Revenue Market Share by Countries
Figure Brazil Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Engineered T Cells Market Share by Product
Table Central & South America Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Engineered T Cells Market Share by End User
Figure Middle East and Africa Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Sales Market Share by Countries
Table Middle East and Africa Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Revenue Market Share by Countries
Figure GCC Countries Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Market Share by Product
Table Middle East and Africa Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Market Share by End User
Table Autolus Limited Company Details
Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Autolus Limited Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Cells Medica Company Details
Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cells Medica Recent Development
Table Elli Lilly and Company Company Details
Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Elli Lilly and Company Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Juno Therapeutics Recent Development
Table Novartis Company Details
Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Oxford Biomedica Company Details
Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Oxford Biomedica Recent Development
Table Pfizer Company Details
Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Precision Bioscience Company Details
Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Precision Bioscience Recent Development
Table Redmile Group Company Details
Table Seeking Alpha Company Details
Table Unum Therapeutics Company Details
Table Global Engineered T Cells Sales Forecast by Regions 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by Regions 2019-2025
Table Global Engineered T Cells Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Engineered T Cells Revenue Market Share Forecast by Regions 2019-2025
Table Global Engineered T Cells Sales Forecast by Product 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by Product 2019-2025
Table Global Engineered T Cells Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Engineered T Cells Revenue Market Share Forecast by Product 2019-2025
Table Global Engineered T Cells Sales Forecast by End User 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by End User 2019-2025
Figure North America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Engineered T Cells Value Chain
Table Engineered T Cells Customers List
Table Engineered T Cells Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Study Coverage
1.1 Engineered T Cells Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Engineered T Cells Market Size Growth Rate by Product
1.4.2 Tumor Infiltrating Lymphocytes
1.4.3 T Cell Receptor {TCR}
1.4.4 Chimeric Antigen Receptor (CAR)
1.5 Market by End User
1.5.1 Global Engineered T Cells Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Engineered T Cells Market Size
2.1.1 Global Engineered T Cells Revenue 2014-2025
2.1.2 Global Engineered T Cells Sales 2014-2025
2.2 Engineered T Cells Growth Rate by Regions
2.2.1 Global Engineered T Cells Sales by Regions
2.2.2 Global Engineered T Cells Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Engineered T Cells Sales by Manufacturers
3.1.1 Engineered T Cells Sales by Manufacturers
3.1.2 Engineered T Cells Sales Market Share by Manufacturers
3.1.3 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
3.2 Engineered T Cells Revenue by Manufacturers
3.2.1 Engineered T Cells Revenue by Manufacturers (2014-2019)
3.2.2 Engineered T Cells Revenue Share by Manufacturers (2014-2019)
3.3 Engineered T Cells Price by Manufacturers
3.4 Engineered T Cells Manufacturing Base Distribution, Product Types
3.4.1 Engineered T Cells Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Engineered T Cells Product Type
3.4.3 Date of International Manufacturers Enter into Engineered T Cells Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Engineered T Cells Sales by Product
4.2 Global Engineered T Cells Revenue by Product
4.3 Engineered T Cells Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Engineered T Cells Breakdown Data by End User
6 North America
6.1 North America Engineered T Cells by Countries
6.1.1 North America Engineered T Cells Sales by Countries
6.1.2 North America Engineered T Cells Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Engineered T Cells by Product
6.3 North America Engineered T Cells by End User
7 Europe
7.1 Europe Engineered T Cells by Countries
7.1.1 Europe Engineered T Cells Sales by Countries
7.1.2 Europe Engineered T Cells Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Engineered T Cells by Product
7.3 Europe Engineered T Cells by End User
8 Asia Pacific
8.1 Asia Pacific Engineered T Cells by Countries
8.1.1 Asia Pacific Engineered T Cells Sales by Countries
8.1.2 Asia Pacific Engineered T Cells Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Engineered T Cells by Product
8.3 Asia Pacific Engineered T Cells by End User
9 Central & South America
9.1 Central & South America Engineered T Cells by Countries
9.1.1 Central & South America Engineered T Cells Sales by Countries
9.1.2 Central & South America Engineered T Cells Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Engineered T Cells by Product
9.3 Central & South America Engineered T Cells by End User
10 Middle East and Africa
10.1 Middle East and Africa Engineered T Cells by Countries
10.1.1 Middle East and Africa Engineered T Cells Sales by Countries
10.1.2 Middle East and Africa Engineered T Cells Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Engineered T Cells by Product
10.3 Middle East and Africa Engineered T Cells by End User
11 Company Profiles
11.1 Autolus Limited
11.1.1 Autolus Limited Company Details
11.1.2 Company Business Overview
11.1.3 Autolus Limited Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Autolus Limited Engineered T Cells Products Offered
11.1.5 Autolus Limited Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bellicum Pharmaceuticals Engineered T Cells Products Offered
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Cells Medica
11.3.1 Cells Medica Company Details
11.3.2 Company Business Overview
11.3.3 Cells Medica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cells Medica Engineered T Cells Products Offered
11.3.5 Cells Medica Recent Development
11.4 Elli Lilly and Company
11.4.1 Elli Lilly and Company Company Details
11.4.2 Company Business Overview
11.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Elli Lilly and Company Engineered T Cells Products Offered
11.4.5 Elli Lilly and Company Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Company Business Overview
11.5.3 Gilead Sciences Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Gilead Sciences Engineered T Cells Products Offered
11.5.5 Gilead Sciences Recent Development
11.6 Juno Therapeutics
11.6.1 Juno Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Juno Therapeutics Engineered T Cells Products Offered
11.6.5 Juno Therapeutics Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Company Business Overview
11.7.3 Novartis Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novartis Engineered T Cells Products Offered
11.7.5 Novartis Recent Development
11.8 Oxford Biomedica
11.8.1 Oxford Biomedica Company Details
11.8.2 Company Business Overview
11.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Oxford Biomedica Engineered T Cells Products Offered
11.8.5 Oxford Biomedica Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Engineered T Cells Products Offered
11.9.5 Pfizer Recent Development
11.10 Precision Bioscience
11.10.1 Precision Bioscience Company Details
11.10.2 Company Business Overview
11.10.3 Precision Bioscience Engineered T Cells Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Precision Bioscience Engineered T Cells Products Offered
11.10.5 Precision Bioscience Recent Development
11.11 Redmile Group
11.12 Seeking Alpha
11.13 Unum Therapeutics
12 Future Forecast
12.1 Engineered T Cells Market Forecast by Regions
12.1.1 Global Engineered T Cells Sales Forecast by Regions 2019-2025
12.1.2 Global Engineered T Cells Revenue Forecast by Regions 2019-2025
12.2 Engineered T Cells Market Forecast by Product
12.2.1 Global Engineered T Cells Sales Forecast by Product 2019-2025
12.2.2 Global Engineered T Cells Revenue Forecast by Product 2019-2025
12.3 Engineered T Cells Market Forecast by End User
12.4 North America Engineered T Cells Forecast
12.5 Europe Engineered T Cells Forecast
12.6 Asia Pacific Engineered T Cells Forecast
12.7 Central & South America Engineered T Cells Forecast
12.8 Middle East and Africa Engineered T Cells Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Engineered T Cells Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Engineered T Cells Product Picture
Table Engineered T Cells Market Segments
Table Key Manufacturers Engineered T Cells Covered
Table Global Engineered T Cells Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Engineered T Cells Sales Market Share by Product 2014-2025
Figure Tumor Infiltrating Lymphocytes Product Picture
Table Major Manufacturers of Tumor Infiltrating Lymphocytes
Figure T Cell Receptor {TCR} Product Picture
Table Major Manufacturers of T Cell Receptor {TCR}
Figure Chimeric Antigen Receptor (CAR) Product Picture
Table Major Manufacturers of Chimeric Antigen Receptor (CAR)
Table Global Engineered T Cells Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Cancer Research Centers
Figure Clinics
Figure Engineered T Cells Report Years Considered
Figure Global Engineered T Cells Market Size 2014-2025 (Million US$)
Figure Global Engineered T Cells Sales 2014-2025 (K Units)
Table Global Engineered T Cells Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Engineered T Cells Sales by Regions 2014-2019 (K Units)
Table Global Engineered T Cells Sales Market Share by Regions 2014-2019
Figure Global Engineered T Cells Sales Market Share by Regions 2014-2019
Figure 2018 Global Engineered T Cells Sales Market Share by Regions
Table Global Engineered T Cells Revenue by Regions 2014-2019 (Million US$)
Table Global Engineered T Cells Revenue Market Share by Regions 2014-2019
Figure Global Engineered T Cells Revenue Market Share by Regions 2014-2019
Figure 2018 Global Engineered T Cells Revenue Market Share by Regions
Table Global Engineered T Cells Sales by Manufacturers (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by Manufacturers (2014-2019)
Figure Global Engineered T Cells Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Engineered T Cells Revenue by Manufacturers (2014-2019) (Million USD)
Table Engineered T Cells Revenue Share by Manufacturers (2014-2019)
Figure Engineered T Cells Value Share by Manufacturers in 2018
Table Key Manufacturers Engineered T Cells Price (2014-2019) (USD/Unit)
Table Engineered T Cells Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Engineered T Cells Product Type
Table Date of International Manufacturers Enter into Engineered T Cells Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by Product (2014-2019)
Figure Global Engineered T Cells Sales Market Share by Product (2014-2019)
Figure Global Engineered T Cells Sales Market Share by Product in 2018
Table Global Engineered T Cells Revenue by Product (2014-2019) (Million US$)
Table Global Engineered T Cells Revenue Share by Product (2014-2019)
Figure Global Engineered T Cells Revenue Market Share by Product (2014-2019)
Figure Global Engineered T Cells Revenue Market Share by Product in 2018
Table Engineered T Cells Price by Product 2014-2019 (USD/Unit)
Table Global Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Global Engineered T Cells Sales Share by End User (2014-2019)
Figure Global Sales Engineered T Cells Market Share by End User (2014-2019)
Figure Global Sales Engineered T Cells Market Share by End User in 2018
Figure North America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure North America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table North America Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 North America Engineered T Cells Sales Market Share by Countries
Table North America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table North America Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Engineered T Cells Revenue Market Share by Countries
Figure United States Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure United States Engineered T Cells Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Canada Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table North America Engineered T Cells Sales by Product (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 North America Engineered T Cells Market Share by Product
Table North America Engineered T Cells Sales by End User (2014-2019) (K Units)
Table North America Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 North America Engineered T Cells Market Share by End User
Figure Europe Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Europe Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Engineered T Cells Sales Market Share by Countries
Table Europe Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Europe Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Engineered T Cells Revenue Market Share by Countries
Figure Germany Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Germany Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure France Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure France Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure UK Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Italy Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Russia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Europe Engineered T Cells Market Share by Product
Table Europe Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Europe Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Europe Engineered T Cells Market Share by End User
Figure Asia Pacific Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Sales Market Share by Countries
Table Asia Pacific Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Revenue Market Share by Countries
Figure China Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure China Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Japan Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Korea Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure India Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure India Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Australia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Market Share by Product
Table Asia Pacific Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Asia Pacific Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Engineered T Cells Market Share by End User
Figure Central & South America Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Engineered T Cells Sales Market Share by Countries
Table Central & South America Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Engineered T Cells Revenue Market Share by Countries
Figure Brazil Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Engineered T Cells Market Share by Product
Table Central & South America Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Central & South America Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Engineered T Cells Market Share by End User
Figure Middle East and Africa Engineered T Cells Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Engineered T Cells Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Engineered T Cells Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Sales Market Share by Countries
Table Middle East and Africa Engineered T Cells Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Engineered T Cells Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Revenue Market Share by Countries
Figure GCC Countries Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Engineered T Cells Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Engineered T Cells Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Engineered T Cells Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Market Share by Product
Table Middle East and Africa Engineered T Cells Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Engineered T Cells Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Engineered T Cells Market Share by End User
Table Autolus Limited Company Details
Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Autolus Limited Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Cells Medica Company Details
Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cells Medica Recent Development
Table Elli Lilly and Company Company Details
Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Elli Lilly and Company Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Juno Therapeutics Recent Development
Table Novartis Company Details
Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Oxford Biomedica Company Details
Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Oxford Biomedica Recent Development
Table Pfizer Company Details
Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Precision Bioscience Company Details
Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Precision Bioscience Recent Development
Table Redmile Group Company Details
Table Seeking Alpha Company Details
Table Unum Therapeutics Company Details
Table Global Engineered T Cells Sales Forecast by Regions 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by Regions 2019-2025
Table Global Engineered T Cells Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Engineered T Cells Revenue Market Share Forecast by Regions 2019-2025
Table Global Engineered T Cells Sales Forecast by Product 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by Product 2019-2025
Table Global Engineered T Cells Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Engineered T Cells Revenue Market Share Forecast by Product 2019-2025
Table Global Engineered T Cells Sales Forecast by End User 2019-2025 (K Units)
Table Global Engineered T Cells Sales Market Share Forecast by End User 2019-2025
Figure North America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Engineered T Cells Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Engineered T Cells Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Engineered T Cells Value Chain
Table Engineered T Cells Customers List
Table Engineered T Cells Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"